PRESS DIGEST - New York Times business news - May 11

May 11 (Reuters) - The following were the top stories in the New York Times business pages on Tuesday. Reuters has not verified these stories and does not vouch for their accuracy.

* Federal financial regulators forged ahead on Monday to try to prevent a repeat of last week's roller-coaster stock ride, though they had not determined the cause of the sudden, steep decline in prices on Thursday.

* Fannie Mae's FNM.N request on Monday for another $8.4 billion in federal aid comes at a politically inconvenient time for the Obama administration, which is pressing to pass sweeping financial legislation without resolving the company's future.

* Genetic tests that assess a person's risk of getting various diseases are heading to the corner drug store. Pathway Genomics, a start-up company, is expected to announce on Tuesday that it will sell such a test through most of the nation's 7,500 Walgreens stores.

* The former ABN Amro Bank agreed to pay $500 million for violating the Bank Secrecy Act, the Justice Department said Monday.

* The Bank of England decided Monday to hold steady on monetary policy after last week's election failed to give any party a governing majority and the recent turmoil in European markets remained a fresh memory.

* Shares of Moody's Corp (MCO.N) fell sharply on Monday after it disclosed that the Securities and Exchange Commission had warned that it might sue the firm for making "false and misleading" statements as part of its application as a ratings organization.